AAAAAA

   
Results: 1-11 |
Results: 11
NEW TEST BENCH FOR THE EXAMINATION OF HIGH-POWER HYDROGEN ENGINES
Authors: MAHR B ESSERS U BRIEM M STERNER A
Citation: B. Mahr et al., NEW TEST BENCH FOR THE EXAMINATION OF HIGH-POWER HYDROGEN ENGINES, International journal of hydrogen energy, 21(7), 1996, pp. 607-612
RECOMBINANT-HUMAN-ERYTHROPOIETIN IN TRANSFUSION-DEPENDENT ANEMIC PATIENTS WITH MULTIPLE-MYELOMA AND NON-HODGKINS-LYMPHOMA - A RANDOMIZED MULTICENTER STUDY
Authors: OSTERBORG A BOOGAERTS MA CIMINO R ESSERS U HOLOWIECKI J JULIUSSON G JAGER G NAJMAN A PEEST D
Citation: A. Osterborg et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN IN TRANSFUSION-DEPENDENT ANEMIC PATIENTS WITH MULTIPLE-MYELOMA AND NON-HODGKINS-LYMPHOMA - A RANDOMIZED MULTICENTER STUDY, Blood, 87(7), 1996, pp. 2675-2682
PHASE-II STUDY OF SUBCUTANEOUS ERYTHROPOIETIN FOR TREATMENT OF MYELODYSPLASTIC SYNDROMES (FAB TYPE-I AND II) - A TRIAL OF THE PHASE-I PHASE-II STUDY-GROUP OF THE ASSOCIATION-FOR-MEDICAL-ONCOLOGY OF THE GERMAN-CANCER-SOCIETY
Authors: HARTUNG G WEIGOLD A OHL S ESSERS U HEIM ME FRITZE D BALDUS M HOELZER D BREMER K QUARDER O EDLER L QUEISSER W
Citation: G. Hartung et al., PHASE-II STUDY OF SUBCUTANEOUS ERYTHROPOIETIN FOR TREATMENT OF MYELODYSPLASTIC SYNDROMES (FAB TYPE-I AND II) - A TRIAL OF THE PHASE-I PHASE-II STUDY-GROUP OF THE ASSOCIATION-FOR-MEDICAL-ONCOLOGY OF THE GERMAN-CANCER-SOCIETY, Onkologie, 18(5), 1995, pp. 451-455
EMISSIONS OF 2-STROKE AND 4-STROKE OUTBOARD ENGINES .1. QUANTIFICATION OF GASES AND VOC
Authors: JUTTNER F BACKHAUS D MATTHIAS U ESSERS U GREINER R MAHR B
Citation: F. Juttner et al., EMISSIONS OF 2-STROKE AND 4-STROKE OUTBOARD ENGINES .1. QUANTIFICATION OF GASES AND VOC, Water research, 29(8), 1995, pp. 1976-1982
EMISSIONS OF 2-STROKE AND 4-STROKE OUTBOARD ENGINES .2. IMPACT ON WATER-QUALITY
Authors: JUTTNER F BACKHAUS D MATTHIAS U ESSERS U GREINER R MAHR B
Citation: F. Juttner et al., EMISSIONS OF 2-STROKE AND 4-STROKE OUTBOARD ENGINES .2. IMPACT ON WATER-QUALITY, Water research, 29(8), 1995, pp. 1983-1987
RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE ANEMIA ASSOCIATED WITH MULTIPLE-MYELOMA OR NON-HODGKINS-LYMPHOMA - DOSE-FINDING AND IDENTIFICATION OF PREDICTORS OF RESPONSE
Authors: CAZZOLA M MESSINGER D BATTISTEL V BRON D CIMINO R ENLLERZIEGLER L ESSERS U GREIL R GROSSI A JAGER G LEMEVEL A NAJMAN A SILINGARDI V SPRIANO M VANHOOF A EHMER B
Citation: M. Cazzola et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE ANEMIA ASSOCIATED WITH MULTIPLE-MYELOMA OR NON-HODGKINS-LYMPHOMA - DOSE-FINDING AND IDENTIFICATION OF PREDICTORS OF RESPONSE, Blood, 86(12), 1995, pp. 4446-4453
RANDOMIZED COMPARISON OF INTERFERON-ALPHA WITH BUSULFAN AND HYDROXYUREA IN CHRONIC MYELOGENOUS LEUKEMIA
Authors: HEHLMANN R HEIMPEL H HASFORD J KOLB HJ PRALLE H HOSSFELD DK QUEISSER W LOFFLER H HOCHHAUS A HEINZE B GEORGII A BARTRAM CR GRIESSHAMMER M BERGMANN L ESSERS U FALGE C QUEISSER U MEYER P SCHMITZ N EIMERMACHER H WALTHER F FETT W KLEEBERG UR KABISCH A NERL C ZIMMERMANN R MEURET G TICHELLI A KANZ L TIGGES FJ SCHMID L BROCKHAUS W TOBLER A REITER A PERKER M EMMERICH B VERPOORT K ZANKOVICH R VONWUSSOW P PRUMMER O THIELE J BUHR T CARBONELL F ANSARI H
Citation: R. Hehlmann et al., RANDOMIZED COMPARISON OF INTERFERON-ALPHA WITH BUSULFAN AND HYDROXYUREA IN CHRONIC MYELOGENOUS LEUKEMIA, Blood, 84(12), 1994, pp. 4064-4077
THE GERMAN CML STUDY, COMPARISON OF BUSULFAN VS HYDROXYUREA VS INTERFERON-ALPHA AND ESTABLISHMENT OF PROGNOSTIC SCORE 1
Authors: HEHLMANN R HEIMPEL H KOLB HJ HEINZE B HOCHHAUS A GRIESSHAMMER M PRALLE H QUEISSER WPD ESSERS U FALGE C BERGMANN L QUEISSER U MEYER P SCHMITZ N WICKRAMANAYAKE PD WALTHER F WESTERHAUSEN M KLEEBERG UR HEILEIN A KABISCH A HEISS F ZIMMERMANN R MEURET G TICHELLI A BERDEL WE TIGGES FJ EIMERMACHER H SCHMID L ZANKOVICH R THIELE J LOFFLER H VONWUSSOW P BUHR T GEORGII A HOSSFELD DK ANSARI H HASFORD J
Citation: R. Hehlmann et al., THE GERMAN CML STUDY, COMPARISON OF BUSULFAN VS HYDROXYUREA VS INTERFERON-ALPHA AND ESTABLISHMENT OF PROGNOSTIC SCORE 1, Leukemia & lymphoma, 11, 1993, pp. 159-168
PROGNOSTIC VALUE OF CLINICAL, LABORATORY, AND HISTOLOGICAL CHARACTERISTICS IN MULTIPLE-MYELOMA - IMPROVED DEFINITION OF RISK GROUPS
Authors: PEEST D COLDEWEY R DEICHER H SAILER M VYKOUPIL C LEO R GEORGII A KAROW J HOEPPNER E DIEHL V ESSERS U GAMM H GLUCK S GORG K GRAMATZKI M HAUSWALDT C HEILMANN E HIEMEYER V KEYSERLINGK HJ KINDLER A OERTEL J PLANKER M REINOLD HM SCHAFER E SCHUMACHER K TIRIER C URBANITZ D SUCHY BR WAHRISCH J
Citation: D. Peest et al., PROGNOSTIC VALUE OF CLINICAL, LABORATORY, AND HISTOLOGICAL CHARACTERISTICS IN MULTIPLE-MYELOMA - IMPROVED DEFINITION OF RISK GROUPS, European journal of cancer, 29A(7), 1993, pp. 978-983
TOPICALLY APPLIED MILTEFOSINE (HEXADECYLPHOSPHOCHOLINE) IN PATIENTS WITH SKIN-METASTASIZED BREAST-CANCER - A PHASE-II STUDY
Authors: UNGER C HERRMANN R BERDEL WE KLEEBERG UR GATZEMEIER U ILLIGER HJ WANDER HE WESTERHAUSEN M BECHER R BREMER K RIECHE K ESSERS U QUEISSER W HEIDEMANN E FIEBIG HH POSSINGER K JOURDAINMADL B HEIM ME EDLER L
Citation: C. Unger et al., TOPICALLY APPLIED MILTEFOSINE (HEXADECYLPHOSPHOCHOLINE) IN PATIENTS WITH SKIN-METASTASIZED BREAST-CANCER - A PHASE-II STUDY, Onkologie, 16(3), 1993, pp. 170-173
RANDOMIZED COMPARISON OF BUSULFAN AND HYDROXYUREA IN CHRONIC MYELOGENOUS LEUKEMIA - PROLONGATION OF SURVIVAL BY HYDROXYUREA
Authors: HEHLMANN R HEIMPEL H HASFORD J KOLB HJ PRALLE H HOSSFELD DK QUEISSER W LOFFLER H HEINZE B GEORGII A VONWUSSOW P BARTRAM C GRIESSHAMMER M BERGMANN L ESSERS U FALGE C HOCHHAUS A QUEISSER U SICK C MEYER P SCHMITZ N VERPOORT K EIMERMACHER H WALTHER F WESTERHAUSEN M KLEEBERG UR HEILEIN A KABISCH A BARZ C ZIMMERMANN R MEURET G TICHELLI A BERDEL WE KANZ L ANGER B TIGGES FJ SCHMID L BROCKHAUS W ZANKOVICH R SCHLAFER U WEISSENFELS I MAINZER K TOBLER A PERKER M HOHNLOSER J MESSENER D THIELE J BUHR T ANSARI H
Citation: R. Hehlmann et al., RANDOMIZED COMPARISON OF BUSULFAN AND HYDROXYUREA IN CHRONIC MYELOGENOUS LEUKEMIA - PROLONGATION OF SURVIVAL BY HYDROXYUREA, Blood, 82(2), 1993, pp. 398-407
Risultati: 1-11 |